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Abstract
The challenge of preventing cardiovascular disease (CVD) in US Hispanics depends upon being 
able to understand and communicate about the diversity within this population in terms of 
environmental exposures, health behaviors, socio-cultural experiences and genetic background to 
CVD risk factor profiles and disease burdens. Recent publications from the Hispanic Community 
Health Study/Study of Latinos (HCHS/SOL) launched by the National Institutes of Health (NIH) 
have begun to accomplish this task. In this article we review some of the HCHS/SOL findings 
concerning cardiometabolic and other CVD risk factors and relate them to the need for increased 
access to health care and attention to lifestyle variables including nutrition. A major challenge that 
needs to be accomplished is to alert our lawmakers, public health officials, health care providers 
and the Hispanic population at large about how to lighten the CVD risk factor and disease burdens 
now carried by our Hispanic population.
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Considerable evidence indicates that the health of a population is strongly influenced by 
economic and social circumstances as well as access to health care services(1,2). Although 
Hispanics living in the United States (US) have less education, a higher poverty rate and 
worse access to health care than non-Hispanic whites, it has been widely reported that 
Hispanics have better health outcomes(3,4;5,6). Thus, the average life expectancy in 2006 for 
Hispanics was 80.6 years, for non-Hispanic whites 78.1 years and for non-Hispanic blacks 
72.9 years(3). The incongruity between the relatively disadvantaged life circumstances of the 
overall Hispanic population and their apparent mortality advantage compared to non-
Hispanic whites is referred to as the Hispanic health paradox.
The limited information available concerning Hispanic health raises important questions and 
potential challenges. First, given the relatively disadvantaged life circumstances of the 
Hispanic population, what can be done to ameliorate the consequences of these 
disadvantages and improve Hispanic health? In order to confront these challenges, we need 
to know how specific adverse circumstances are influencing health among Hispanics. 
Second, is the mortality advantage among Hispanics accompanied by good health and 
perceived health quality of life? Third, how widely does the morbidity in the overall 
Hispanic population vary as a function of ethnic background or geographic location? Fourth, 
does the prevalence of morbidity vary between those born in the US and those who have 
immigrated, and how does duration of time living in the US relate to morbidity? Fifth, is the 
apparent mortality advantage enjoyed by the Hispanic population likely to last? Given the 
substantial changes that have been occurring in recent decades in Hispanic population size, 
shifting demographics and changing lifestyles, it is conceivable that belief in the 
sustainability of the Hispanic mortality advantage may be promoting a false sense of 
security among public health officials, health care providers and the Hispanic population. 
This could have severe negative consequences. The purpose of the present paper is to 
examine the preceding questions within the context of early research findings from the 
Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
According to the 2010 US Census, there are approximately 50.5 million Hispanics in the 
US, comprising about 16% of the population(7). Demographers expect that the proportion of 
Hispanics will grow to 30% by the year 2050(8). Although Hispanics are a diverse group in 
terms of sociocultural and genetic backgrounds, there is a paucity of information about 
Hispanic health derived from national exams and surveys. The National Health and 
Nutrition Examination Survey (NHANES), initiated in 1959, consists of a series of 
programs that combines interviews and physical examinations to assess the health and 
nutritional status in a nationally representative sample of adults and children in the US(9,10). 
Until 2010 NHANES’ Hispanic arm was almost exclusively Mexican-American. Thus, 
participants were classified as non-Hispanic white, non-Hispanic black and Mexican-
Americans. NHANES assesses a variety of health variables and indicators, but does not 
assess the incidence of chronic diseases. The Hispanic Health and Nutrition Examination 
Study (HHANES), conducted between 1982 and 1984, examined 11,653 Hispanics in a one-
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time cross sectional examination of the prevalence of specific health factors(11,12,13). Carried 
out in a manner similar to NHANES, it provided a nationally representative sample of 
individuals from Mexican, Puerto Rican and Cuban origins enrolled in Texas, Colorado, 
New Mexico, Arizona, California, Florida, New York, New Jersey and Connecticut. The 
survey was estimated to represent 76% of the total 1980 US Hispanic civilian population. 
Although a valuable contribution to the study of Hispanic health, the data are now more than 
30 years old.
In order to characterize the contemporary health status, health risks and CVD disease burden 
of Hispanics living in the US and to identify likely causal factors of many chronic diseases 
in a population with diverse environmental exposures, genetic backgrounds and early life 
experiences, the US National Institutes of Health (NIH) launched the HCHS/SOL with the 
National Heart, Lung and Blood Institute (NHLBI) serving as the lead sponsor.
The design and sampling methods of HCHS/SOL have previously been described(14,15). 
Briefly, HCHS/SOL is a longitudinal cohort study of 16,415 Hispanics, aged 18–74 years at 
their baseline visit in 4 of 11 urban metropolitan areas with the largest number of Hispanics 
in the US (Bronx, NY: Chicago, IL; Miami, FL; and San Diego, CA)(16). The cohort self-
identified as Mexican, Puerto Rican, Cuban, Dominican, Central or South American. 
HCHS/SOL used a stratified 2-stage area probability sample design in which census blocks 
were randomly selected in the defined community areas of each field center, and households 
were randomly selected in each sampled block group. Sampling weights were established 
based on the probability of selection, adjustment for non-response, trimming to handle 
extreme values of the weights, calibration to the known population distribution and 
normalization to the entire HCHS/SOL target population based on the 2010 US census. At 
baseline (2008–2011) participants underwent a clinical exam that included assessment of 
CVD risk factors (e.g., elevated blood pressure, diabetes mellitus/DM, dyslipidemia, 
smoking, obesity, sleep apnea) and information on demographics, medical history, 
medication usage, diet, physical activity, socioeconomic and sociocultural (acculturation) 
factors. The study also involves annual follow-up data since 2009 and a planned second 
clinic visit for each participant from 2014–2017.
Cardiometabolic Risk Factors
Various cardiometabolic risk factors have been examined in HCHS/SOL including the 
prevalence of: (a) DM, (b) metabolic syndrome (MetS), (c) obesity, (d) hypertension (HTN) 
and (e) sleep disordered breathing (SDB).
Diabetes Mellitus
DM increases the risk for coronary heart disease (CHD) or stroke approximately two-
fold(17) and 2 of 3 people with DM die of cardiovascular disease (CVD)(18). In HCHS/SOL 
DM is associated with increased prevalence of both CHD and stroke(19); DM in the 
HCHS/SOL was defined as having a fasting plasma glucose ≥ 126 mg/dL or impaired 
glucose tolerance as indicated by a glucose level ≥ 200 mg/dL after a two-hour oral glucose 
tolerance test or elevated glycosylated hemoglobin (A1c ≥ 6.5%; 48 mmol/mol) or 
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documented (scanned) use of hypoglycemic agents(20). In a few specific analyses (e.g., 
examining DM awareness), self-reported DM was assessed.
Although the prevalence of DM in HCHS/SOL using only objective measures was 16.9, the 
prevalence of diabetes across the 6 heritage groups ranged from 10.2 in South Americans to 
18.3 in those from Mexican backgrounds (Table 1)(20). Differences in prevalence as a 
function of Hispanic background remained significant after controlling for age, sex, body 
mass index (BMI), field center and years living in the US (p<.0001). Using slightly different 
metrics in those 20 years and older from 2007–2009 and sex and age standardized to the 
2000 US population (the HCHS/SOL data are from 2008–2011 and age standardized to the 
2010 US population), the Centers for Disease Control and Prevention (CDC) reported a 
prevalence estimate of 10.2% in non-Hispanic whites and 18.7% for non-Hispanic 
blacks(21). Thus the range of DM prevalence among Hispanics/Latinos appears to 
approximate the prevalence range between non-Hispanic whites and non-Hispanic blacks. 
Moreover, the diversity in DM prevalence across Hispanic background groups is consistent 
with there being other variations in CVD risk factors observed among Hispanic groups in 
HCHS/SOL(19).
For those not born in the US, prevalence of DM increased from 12.3 for those living in the 
US for 5 years or less to a mean of 18.8 for those living in the US for more than 15 years(20). 
The prevalence of DM in those living in the US for more than 10 years was higher than 
those living in the US 10 years or less after adjusting for age, sex, BMI, Hispanic 
background and field center community (p<0.02). However, the prevalence of DM in those 
living in the US ≤ 5 years did not differ from those born in the US after adjusting for the 
same variables. The present finding that DM prevalence significantly increased in relation to 
length of residence in the US is consistent with the findings of the National Health Interview 
Survey(22). In contrast, the HCHS/SOL finding that participants born in the US did not differ 
significantly from those living in the US for 5 years or less is not consistent with the report 
that immigrants to the US are healthier than US born people of similar ethnic 
background(23). Thus, the HCHS/SOL data confirm that migrant health tends to worsen with 
increased duration of living in the US, but is apparently not due to initial health status.
In a similar vein, several reports have indicated that African immigrants have less obesity, 
better cardiometabolic health and greater longevity than African Americans(24,25). However, 
a recent study has indicated that while African immigrant men were less obese than African 
American men, they had worse cardiometabolic health including higher glucose levels, more 
HTN, and greater visceral adiposity(26). This suggests that the supposed healthy immigrant 
effect may not be valid for either Hispanic or African immigrants.
The HCHS/SOL found that prevalence of DM is negatively related to household income 
(p=0.0004) and education (p=0.0005)(20). Thus, the prevalence of DM was 16.9 and 18.5, 
respectively for men and women with household income less than $20,000 per year but was 
12.8 and 8.3, respectively, in men and women with household incomes above $75,000 per 
year. Similarly prevalence of DM was 18.6 and 20.1, respectively, for men and women who 
had not completed high school but 15.4 and 12.9, respectively, for men and women who had 
more than a high school education. Interactions between sex and either household income or 
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education were not significant. The HCHS/SOL findings are consistent with those of a 
large-scale meta-analysis of type 2 DM(T2DM) incidence and socioeconomic status carried 
out worldwide(27). That study found that risk of getting T2DM was associated with low 
socio-economic status including education and income in high-, middle-, and low-income 
countries. Moreover, the relationship was strongest in high-income countries such as the US
Among the HCHS/SOL participants with DM, 41.3% were unaware of their condition(20), 
which is about the same as those reported for non-Hispanic whites(10). In contrast, the rate of 
adequate glycemic control (A1c <7.0; <53 mmol/mol) for Hispanics in the HCHS/SOL 
(48.0%) appears to be somewhat lower than those for either non-Hispanic blacks (52.6%) or 
non-Hispanic whites (52.9%) reported by NHANES for 2007–2010(28). The rate of glycemic 
control for Hispanics in NHANES was 47.3%, which, together with the HCHS/SOL 
observations, indicate that fewer Hispanics with DM have adequate glycemic control.
It should be noted that among the HCHS/SOL participants at the baseline visit who had DM, 
only 52% had health insurance(20). The percent of participants with health insurance 
(p=0.0001), DM awareness (p=0.0001) and glycemic control (p=0.0299) increased 
significantly with age after controlling for sex, Hispanic background, BMI, field center, 
education and years living in the US. Individuals with health insurance were less likely to 
present at the baseline exam with unrecognized diabetes (p=0.003). Those ≥ 65 years had 
greater rates of DM awareness (p=0.0001), glycemic control (p=0.0106) and insurance 
coverage (p=0.0001) than those < 65 years.
Given the above information, it is interesting to note that the percentage of Hispanic adults 
aged 18–64 years lacking health insurance in the National Health Interview Survey for 2008 
was 41.6% compared with 14.6% in non-Hispanic Whites and 22.1% in non-Hispanic 
Blacks(29). A meta-analysis comparing A1c levels between Hispanics and non-Hispanic 
white adults with DM found that A1c was 0.5% (5.5 mmol/mol) higher among 
Hispanics(30). Although the reasons for the disparity in glycemic control between Hispanics 
and non-Hispanic whites have not yet been investigated, the implications appear to be 
important. Thus, the apparent similarity of DM awareness between non-Hispanic whites and 
Hispanics in conjunction with a large disparity in health insurance between the groups, 
suggest that the differences in health insurance and/or other aspects of access to health care 
such as ability to meet co-payments, may well account for the differences in glycemic 
control. This would appear to be particularly important, because a decrease of 0.5% (5.5 
mmol/mol) in A1c is associated with a 10.5% decrease in risk of vascular complications(31).
Metabolic Syndrome
The MetS is a cluster of anthropometric, hemodynamic and metabolic disturbances that has 
been associated with increased risk for DM(32) and CVD morbidity and mortality(33). 
Previous reports have noted that the MetS disproportionally affects Hispanics/Latinos with 
NHANES 1888–1994, for example, showing that Mexican Americans had the highest 
prevalence(34).
The HCHS/SOL defined the MetS according to the American Heart Association (AHA)/
NHLBI 2009 Joint Interim Statement that requires three or more of the following 
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components: (1) waist circumference ≥102 cm in men and ≥88 cm in women; (2) blood 
pressure ≥130 mm Hg systolic and/or ≥ 85 mm diastolic; (3) triglycerides ≥150 mg/dL; (4) 
high-density lipoprotein cholesterol <40 mg/dL; and (5) fasting glucose ≥100 mg/dL and or 
(6) on relevant medication. The age standardized prevalence of the MetS was 33.7% among 
men and 36.0% among women (Table 2)(35). These estimates are comparable to those 
presented by other national samples(36,34) that have suggested that there is a higher 
frequency of occurrence of the MetS among Hispanics/Latinos when compared to Non-
Hispanic whites and/or African Americans. There was significant variability in the 
prevalence of the MetS among HCHS/SOL participants of different Hispanic/Latino 
background(35). Puerto Rican women had the highest prevalence at 40.9% while South 
American men had the lowest at 27.0% (Table 2). The prevalence of the MetS increased 
steeply with age and was as high as 72.0% among women between the ages of 70–74 years 
(Table 2)(35).
The most common components among participants with the MetS were abdominal obesity 
(73%), hyperglycemia (73%) and hypertriglyceridemia (73%) for men and abdominal 
obesity (96%) followed by low high-density lipoprotein cholesterol (75%) for women. 
Further, among HCHS/SOL participants 14% of women and 21% of men had no 
cardiometabolic abnormalities, while 3.8% of men and 4.6% of women had five(35).
Obesity
During the past decades, the prevalence and severity of obesity have increased in US adults 
of all ethnicities. National estimates have highlighted the increased vulnerability of 
Hispanics/Latinos to be classified as obese(37,38). However, to date most studies have almost 
exclusively included Hispanics of Mexican descent.
The HCHS/SOL examined the prevalence and severity of Hispanics/Latinos of various 
backgrounds using the following BMI categories: class I obesity BMI≥ 30 kg/m2; class II 
obesity BMI≥ 35; and class III obesity BMI≥ 40 kg/m2. Results showed that among 
HCHS/SOL participants, women were more likely to be obese than men(39). The prevalence 
of class I obesity was 37% and 42% for men and women, respectively. Approximately 8% 
of men and 11% of women met criteria for class II obesity and 4% and 7% of men and 
women, respectively, met criteria for class III obesity. Thus, one in five women and one in 
ten men within the HCHS/SOL cohort were classified as having class II or III obesity.
The impact of obesity on other cardiometabolic risk factors has been assessed in HCHS/
SOL. Participants with elevated BMI were found to have high prevalences of traditional and 
novel CVD risk factors including DM, hypertension, low-density lipoprotein cholesterol, 
hypertriglyceridemia and increased inflammation (high C-reactive protein)(39).
Hypertension
HTN has long been identified as a major risk factor for CVD. In HCHS/SOL, HTN was 
strongly associated with the prevalence of CHD and stroke(19). Although there have been 
significant improvements in the prevention and treatment of HTN during the last decades, 
blood pressure prevalence in the US population remains at undesirable levels.
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In HCHS/SOL, the overall age-adjusted prevalence of HTN was 25.5% (26.1% for men and 
25.3% for women)(19,40); HTN was defined as average measured blood pressure of ≥140 
mm Hg systolic or 90mm Hg diastolic or self-reported use of medications for HTN in the 
last 4 weeks. When compared to national estimates, prevalence rates of HTN reported by 
HCHS/SOL were comparable to those found in NHANES 2009–2010 for Hispanic 
participants (26.1%) and slightly lower than those reported for Non- Hispanic white 
participants (27.4%)(41).
The prevalence of HTN varied significantly across Hispanic background, with South 
American women having the lowest rates at 17.2% and Dominican men having the highest 
at 34.3%(40). Interestingly, in HCHS/SOL the prevalence of HTN varied across study sites. 
Thus, within Hispanic backgrounds, there were differences in the prevalence of HTN 
according to geographic location. In fact, the Chicago site showed lower HTN prevalence 
for several Hispanic subgroups including Central and South Americans(40). Finally, it is 
worth highlighting that the prevalence rates of HTN did not vary according to education 
level or income.
In addition to identifying HTN prevalence estimates and in order to better identify and 
address the specific needs of the Hispanic population, HCHS/SOL sought to examine the 
percentage of those with hypertension who (1) were aware of their condition, (2) were being 
treated with medications, and (3) had adequately controlled blood pressure. Participants 
were defined as “aware of HTN status” if they were classified as having HTN and they 
reported being informed by a medical provider that they had HTN. Participants were defined 
as “treated” if they were classified as having HTN and reported that they were taking 
medications for HTN. Further, participants’ HTN were classified as “controlled” if they 
were classified as having HTN (self-reported use of medications) and the measured blood 
pressure was <140/90 mm Hg.
The HCHS/SOL reported overall rates of awareness, treatment and control of 74.1%, 63.4% 
and 37.5%, respectively(40). Of concern is the fact that these percentages are markedly lower 
than those reported by other national estimates, particularly when it comes to HTN control. 
While the percent controlled in the HCHS/SOL was only 37.5, NHANES 2009–2010 data 
showed 40.7% of Hispanics and 56.3% of Non-Hispanic Whites had controlled HTN(41).
In HCHS/SOL, men and women showed some differences in terms of their levels of 
awareness, treatment and control(40). Among men, younger participants were less likely to 
be aware of and treated for their HTN and those within the 18 to 29 year old category had 
the most alarming rates. Within this age group, only 48% were classified as being aware of 
their condition, only 19% of them were treated for HTN and only 17% had controlled HTN. 
Among women, awareness and treatment increased steeply with age. Those in the oldest age 
category (70–74 years old) had the highest percentages of awareness and treatment (79% 
and 71%, respectively). However, they were the least likely to have controlled HTN with a 
percentage of only 30% in this category.
HTN awareness, treatment and control varied significantly among men, but not women, of 
different Hispanic background(40). Central American men were found to be at considerable 
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disadvantage as they had the lowest percentages of HTN awareness at 57%. Similarly, only 
39% of men within this Hispanic subgroup were treated and only 12% had controlled HTN. 
In contrast, Cuban men showed the greatest percentages of awareness, treatment and control 
with 78%, 65% and 40%, respectively. Levels of awareness, treatment and control were 
comparable among women across Hispanic background. These percentages were also 
comparable among men and women across education and income levels.
Of considerable note in this regard was the finding that in the HCHS/SOL study sample, the 
proportion of individuals who were aware, treated and controlled for HTN differed 
significantly by health insurance status(40). This is not an unusual finding in the CVD health 
literature. In fact, the Agency of Healthcare Research and Quality latest report indicates that 
health insurance is the single most important factor relating to access to care. Similarly, a 
recent study using data from the Behavioral Risk Factor Surveillance System showed that 
lack of health insurance is the most important predictor of not having a personal doctor or 
health care provider or the inability to afford to visit a doctor(42). Interestingly, this study 
also found important ethnic disparities in access to care among those with HTN and in line 
with HCHS/SOL study results, showed that those of younger age and those classified as 
Hispanics were more likely to report barriers in access to care(42).
Sleep Disordered Breathing
SDB is characterized by episodes of partial or complete upper airway collapse during sleep, 
leading to intermittent cyclic hypoxemia and sleep fragmentation(43,44). SDB has been 
associated with various CVD risk factors, including HTN and metabolic conditions(45,46) 
and has been implicated in the etiology of CVD, including CHD(47), congestive heart 
failure(48,49), and stroke(50). In HCHS/SOL severe SDB was associated with a 50% increase 
in the odds of presenting with impaired glucose tolerance and 90% higher odds of prevalent 
DM(51). In addition, SDB was associated with HTN particularly among participants of 
Puerto Rican and Central American backgrounds(51).
Participants in HCHS/SOL were instructed in the use of a sleep apnea monitor overnight in 
order to determine the presence of SDB. Sleep records were scored by certified 
polysomnologists at a central sleep reading center and the apnea-hypopnea index (AHI), 
number of respiratory events per estimated sleep hour, was used to determine the severity of 
SDB. AHI values of 5–14, 15–29, and ≥ 30 were used to define minimal, moderate and 
severe SDB, respectively. SDB was defined as having both an AHI ≥ 5 and endorsement of 
sleepiness as indicated by the Epworth Sleepiness Scale. Overall, 25.8% of the HCHS/SOL 
participants met minimal criteria, 9.8% met moderate and 3.9% severe criteria for SDB(51).
In line with the literature, men, those classified as overweight or obese, and those reporting 
habitual snoring or “stop breathing” while asleep had increased odds of SDB(51). 
Alarmingly, in spite of the high prevalence of SDB within the HCHS/SOL cohort, only 
1.3% of study participants reported a previous physician diagnosis of obstructive sleep 
apnea (high SDB and daytime sleepiness)(51). Given the high risk that untreated severe SDB 
conveys(52), particularly in regards to CVD and metabolic conditions, it is likely a large 
burden of disease may be attributable to unawareness and, thus, untreated SDB among 
Hispanic/Latinos in the US.
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During the last decade, important changes in lifestyle patterns have led to an increased 
prevalence of chronic conditions, including CVD and DM. In fact, the leading causes of 
death can be attributable to changes in lifestyle risk factors, including but not limited to: (a) 
smoking; and (b) poor dietary habits.
Smoking
Given that few national surveys have specifically examined smoking among US Hispanics, 
the HCHS/SOL sought to do so. Within this study, self-report was used to define current and 
past smokers. Results indicated that smoking behaviors varied widely across Hispanic 
groups. Prevalence of current smoking was highest among Puerto Ricans (35.0% for men, 
32.6% for women) and Cubans (31.3% for men, 21.9% for women) and lowest among 
Dominicans (11.0% for men, 11.7% for women)(53). Prevalence of current smoking among 
Puerto Ricans and Cubans was comparable to that of African Americans but largely 
exceeded the estimates for non-Hispanic whites (22.6%)(54), highlighting the need to 
develop interventions specifically targeting Hispanics of Puerto Rican and Cuban descents.
Men, those younger than 60 years, and those with lower income and education were more 
likely to be smokers(53). Smoking was more common among those who were born in the US 
and those with higher levels of acculturation, suggesting vulnerability (particularly among 
women) to acculturation stress and media or cultural influences that may promote smoking 
in the US.
The likelihood of quitting was higher among older people with higher levels of socio-
economic status (income and education)(53). Although quitting was not associated with 
health insurance status, the proportion of participants who had ever used prescription or 
over-the-counter smoking-cessation products was significant higher (p<0.05) among those 
with health insurance. In fact, use of smoking-cessation products was low in the overall 
HCHS/SOL sample suggesting the need for increasing availability, awareness and 
acceptability of these products among Hispanics.
Nutrition
Dietary habits usually reflect cultural origin and country of origin. Although Hispanics/
Latinos are often thought of as a homogenous group, the HCHS/SOL set out to examine the 
heterogeneity of this population. Dietary habits were assessed using two 24-hour recalls 
(Nutrition Data System for Research Software). Mean total energy intake varied 
significantly across Hispanic/Latino subgroups with Cubans reporting the highest mean 
intake at 2235 kcal and Dominicans the lowest at 1708 kcal(55). Differences in nutrient and 
food-group intake appeared to reflect difference in prevalence rates of CVD and its risk 
factors reported in HCHS/SOL(19). For instance, Cubans and Puerto Ricans showed higher 
intakes of foods and nutrients associated with CVD risk such as total and saturated fat, 
sodium, refined carbohydrates and red meats, as well as lower intakes of foods associated 
with reduced CVD risk including fiber, fish and fruits(55). The opposite was true for South 
Americans (those with the lowest CVD risk in HCHS/SOL) who reported lower intake of 
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nutrients that promote CVD. In fact, South Americans appear to generally follow guidelines 
isomorphic to those established by the AHA(56). These results highlight the importance of 
good dietary habits as a determinant of cardiovascular health and the need for developing 
interventions targeting specific Hispanic background groups.
Periodontitis—In the US, prevalence of periodontitis has been estimated to be higher 
among Hispanic/Latinos when compared to Non-Hispanic Whites(57). However, little is 
known about variations in periodontal health among Hispanics from diverse backgrounds. In 
terms of the risk for CHD, components of MetS, including obesity, high triglycerides, low 
high-density lipoprotein cholesterol, HTN, and high plasma glucose have been associated 
with periodontal disease possibly related to inflammatory and immune host responses to 
pathogenic microorganisms and their byproducts(58,59,60). Similarly, in people with DM, 
periodontal infection is associated with greater carotid artery intima-medial wall 
thickness(61) and elevated risk of CHD(62).
Periodontal health was examined in HCHS/SOL and periodontitis was classified according 
to the Centers for Disease Control and Prevention and American Academy of 
Periodontology definitions as mild, moderate, and severe(57,63). The age-adjusted prevalence 
of moderate and severe periodontitis was 38.5% and varied significantly across Hispanic 
heritage backgrounds(63). Central Americans had the highest estimates and Dominicans the 
lowest. It is important to note, that Central Americans were distinguished from other groups 
in being least likely to have used dental services within 5 years and having the smallest 
proportion in the high household income category. In contrast, Dominicans had the 
healthiest behavioral profile with respect to nonsmoking, central adiposity and recent use of 
dental services, which may have offset the hazard of their relatively poor socioeconomic 
status.
Level of acculturation was associated with periodontitis prevalence(63). In fact, compared to 
people with short duration of US residence, people with longer duration of US residence had 
lower prevalence of periodontitis, adjusting for all covariates, as did people with English 
language preference. This suggests that the effect of acculturation on pathophysiology is 
likely complex, and the influence of acculturation on health risks and outcomes may vary by 
disease.
Discussion
Although Hispanics living in the US have less education, a higher poverty rate, and worse 
utilization and access for health care, life expectancy for Hispanics in 2006 was greater for 
Hispanics than for non-Hispanic whites(3). This snapshot in time may be misleading since 
substantial changes have occurred in recent decades in the US in terms of Hispanic 
population size, immigration patterns, demographics, lifestyle practices and cardiometabolic 
risk. The baseline visits to HCHS/SOL, conducted from 2008–2011, documented high 
prevalences of CVD risk factors among Hispanics(19) especially for cardiometabolic risk 
factors including DM(20), MetS(35), obesity(39), HTN(40) and SDB(51). Metabolic syndrome 
occurred more often in Hispanics compared to non-Hispanic whites and/or African 
Americans(36,35). In HCHS/SOL abdominal obesity (73% in men; 96% in women) was the 
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most common component of MetS(35). Conversely, participants with elevated BMI had high 
prevalences of traditional and novel CVD risk factors including DM, HTN, low-density 
lipoprotein cholesterol, hypertriglyceridemia and increased inflammation as indicated by 
elevated C-reactive protein(39). In summary, Hispanics in HCHS/SOL revealed a great deal 
of overweight and obesity and this was associated with high prevalence of cardiometabolic 
risk factors that are likely to unfavorably impact CVD mortality.
A major lesson learned from HCHS/SOL is that Hispanics in the US constitute a highly 
heterogeneous population. The prevalence of MetS(35), obesity(19), DM(20) and HTN(40) in 
HCHS/SOL was lowest in South Americans and appeared to be related to consumption of a 
nutritious diet consistent with AHA guidelines(55). In contrast, obesity, DM, HTN and 
hypercholesterolemia were all highest in Puerto Ricans compared to other women in the 
cohort(19) and this too appeared to be related to diet(55). The data suggest that there are large 
variations in cardiometabolic risk among diverse US Hispanic background groups, and that 
these differences are related to diet. It should also be noted that the prevalence of smoking 
was highest for each sex among Puerto Ricans. In addition, HCHS/SOL has found that 
major ECG abnormalities occurred more frequently in those from Puerto Rican and 
Dominican than from Mexican American backgrounds(64).Thus, there appears to be a need 
to focus upon changes in preventive health behaviors among specific Hispanic background 
groups (e.g., Puerto Ricans) in order to promote CVD health among US Hispanics.
Another important lesson learned from HCHS/SOL is the importance of health insurance 
and access to health care in the control of CVD risk factors such as DM(20) HTN(40) and 
periodontal disease(63). These findings are particularly important because the percentage of 
participants insured in HCHS/SOL was only 50.9% including those receiving medicare or 
Medicaid benefits(19). Although the percentage of HCHS/SOL participants who were 
unaware of their DM(20) was comparable to those reported for non- Hispanic whites(10), the 
rate of adequate glycemic control in HCHS/SOL was considerably lower than that reported 
for either non-Hispanic blacks or non-Hispanic whites(28). As previously noted, however, 
those individuals at least 65 years old had greater rates of DM awareness, glycemic control 
and insurance coverage than those under age 65. In similar fashion the proportion of people 
who were aware, treated and controlled for HTN differed by health insurance status(40). 
Interestingly, in terms of periodontal disease in HCHS/SOL, Dominicans had the least 
periodontal disease and used dental services most during the preceding 5 years, whereas 
Central Americans had the most periodontal disease and used dental services least. It is of 
interest that the baseline visits for HCHS/SOL were all completed before implementation of 
the US Patient Protection and Affordable Care Act of 2010 and the second examination 
visits will be conducted between October 2014 and September 2017. Consequently, the 
HCHS/SOL will be able to monitor changes in health care coverage and examine some of 
their effects upon health practices, risks and status.
In conclusion, the major challenges needed to reduce CVD risk factors and disease burden in 
the US Hispanic population will be to inform our lawmakers, public health officials, health 
care providers and the Hispanic population about the current problems with Hispanic CVD 
health and what needs to be done to correct them. The solutions will require improved 
preventive education and intervention procedures to stop smoking, maintain proper weight 
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and correct poor nutrition. They will also require providing better health care access to the 
Hispanic population.
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Table 2
Age-standardized* Prevalence (95% Confidence Interval) of the Metabolic Syndrome by Hispanic/Latino 







Overall (N of Observations) 35.0 (34.0, 36.1) 33.7 (32.2, 35.2) 36.0 (34.6, 37.4)
Hispanic/Latino background
  Dominican (1,457) 31.5 (29.0, 34.0) 30.6 (26.3, 35.2) 32.2 (28.9, 35.8)
  Central American (1,725) 35.8 (33.0, 38.7) 32.6 (28.5, 36.9) 37.7 (34.7, 40.8)
  Cuban (2,343) 34.8 (32.6, 37.0) 34.7 (31.9, 37.6) 34.9 (32.0, 37.9)
  Mexican (6,451) 35.0 (33.2, 36.9) 33.7 (31.3, 36.2) 36.0 (33.5, 38.6)
  Puerto Rican (2,702) 37.1 (34.4, 39.9) 32.6 (28.7, 36.8) 40.9 (37.4, 44.6)***
  South American (1,063) 27.3 (24.2, 30.7)* 27.0 (22.3, 32.4) 26.8 (23.1, 30.9)**
Age Groups (years)
  18–29 (2,644) 12.7 (11.1, 14.4) 12.9 (10.8, 15.3) 12.4 (10.3, 14.9)
  30–39 (2,375) 24.7 (22.5, 27.1) 27.1 (23.6, 30.9) 22.4 (19.5, 25.7)
  40–49 (4,194) 36.7 (34.5, 39.0) 36.1 (32.9, 39.4) 37.3 (34.5, 40.1)
  50–59 (4,323) 48.6 (45.9, 51.4) 44.8 (41.3, 48.4) 51.6 (48.2, 55.1)
  60–69 (2,283) 56.8 (53.8, 59.8) 52.3 (47.7, 56.9) 60.6 (56.3, 64.7)
  70–74 (500) 66.6 (60.3, 72.3) 58.0 (49.6, 65.9) 72.0 (63.5, 79.3)
*
Values weighted for survey design and nonresponse and age standardized to the Census 2010 U.S. population.
Statistically significant differences (p<0.05) were seen between Hispanic/Latino backgrounds overall*,
among women**,
and between sex***
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